Axa S.A. Biogen Inc. Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Axa S.A. holds 57,959 shares of BIIB stock, worth $9.32 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

57,959

Previous 72,002 19.5%

Holding current value

$9.32 Million

Previous $16.7 Million 32.69%

% of portfolio

0.03%

Previous 0.05%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $2.66 Million - $3.33 Million	-14,043 Reduced 19.5%	57,959 $11.2 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $64 Million - $79.5 Million	-335,836 Reduced 82.35%	72,002 $16.7 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $9.1 Million - $11.5 Million	-42,905 Reduced 9.52%	407,838 $87.9 Million
Q4 2023 Jul 16, 2024	BUY	$222.59 - $267.94 $9.55 Million - $11.5 Million	42,905 Added 10.52%	450,743 $117 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $2.11 Million - $2.54 Million	9,494 Added 2.15%	450,743 $117 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $265,205 - $299,326	1,047 Added 0.24%	441,249 $113 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $6.66 Million - $7.7 Million	24,198 Added 5.82%	440,202 $125 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $7.52 Million - $8.57 Million	29,308 Added 7.58%	416,004 $116 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $34.6 Million - $42 Million	136,991 Added 54.86%	386,696 $107 Million
Q3 2022 Feb 14, 2023	BUY	$194.69 - $268.46 $7.02 Million - $9.68 Million	36,058 Added 16.88%	249,705 $66.7 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $7.02 Million - $9.68 Million	36,058 Added 16.88%	249,705 $66.7 Million
Q2 2022 Feb 14, 2023	BUY	$187.54 - $223.02 $1.93 Million - $2.3 Million	10,292 Added 5.06%	213,647 $43.6 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $1.93 Million - $2.3 Million	10,292 Added 5.06%	213,647 $43.6 Million
Q1 2022 Feb 14, 2023	SELL	$193.77 - $244.14 $8.98 Million - $11.3 Million	-46,350 Reduced 18.56%	203,355 $42.8 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $3.53 Million - $4.44 Million	-18,198 Reduced 8.21%	203,355 $42.8 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $2.66 Million - $3.41 Million	11,866 Added 5.66%	221,553 $53.2 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $4.46 Million - $5.81 Million	15,754 Added 8.12%	209,687 $59.3 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $6.23 Million - $9.97 Million	24,043 Added 14.15%	193,933 $67.2 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $5.62 Million - $6.59 Million	23,137 Added 15.77%	169,890 $47.5 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $9.41 Million - $14.2 Million	-39,814 Reduced 21.34%	146,753 $35.9 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $17.9 Million - $20.7 Million	-67,621 Reduced 26.6%	186,567 $52.9 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $17.8 Million - $23.6 Million	68,828 Added 37.13%	254,188 $68 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $1,344 - $1,705	5 Added 0.0%	185,360 $58.6 Million
Q4 2019 Feb 18, 2020	BUY	$220.06 - $304.07 $4.69 Million - $6.48 Million	21,326 Added 13.0%	185,355 $55 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $6.63 Million - $7.43 Million	-30,483 Reduced 15.67%	164,029 $38.2 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $5.83 Million - $6.43 Million	-26,592 Reduced 12.03%	194,512 $45.5 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $28.1 Million - $44 Million	-129,765 Reduced 36.98%	221,104 $52.3 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $9.91 Million - $12.6 Million	-35,598 Reduced 9.21%	350,869 $106 Million
Q3 2018 Nov 08, 2018	BUY	$293.51 - $383.83 $549,744 - $718,913	1,873 Added 0.49%	386,467 $137 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $283,014 - $337,294	1,099 Added 0.29%	384,594 $112 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $595,437 - $842,145	2,289 Added 0.6%	383,495 $105 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $12.3 Million - $13.8 Million	-40,016 Reduced 9.5%	381,206 $121 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $118 Million - $139 Million	421,222	421,222 $132 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account